Skip to main content

Table 5 Comparison between the change in QOl in group A and group B

From: The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia

   Mean rank P-value
Quality of life (before) Tamsulosin only 100.37 0.970
Tamsulosin plus solifenacin 100.63
Quality of life (after) Tamsulosin only 138.98 < 0.001
Tamsulosin plus solifenacin 62.02
P value Mean rank   
0.970 100.37 Tamsulosin only Quality of life (before)
100.63 Tamsulosin plus solifenacin
< 0.001 138.98 Tamsulosin only Quality of life (after)
62.02 Tamsulosin plus solifenacin